|
KIAA1632 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.600850E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.586300E-04 |
| Normal-vs-Stage2 |
4.481400E-03 |
| Normal-vs-Stage3 |
2.042500E-04 |
| Normal-vs-Stage4 |
1.046160E-02 |
| Stage1-vs-Stage2 |
5.937200E-01 |
| Stage1-vs-Stage3 |
3.431200E-01 |
| Stage1-vs-Stage4 |
8.718800E-01 |
| Stage2-vs-Stage3 |
8.862400E-01 |
| Stage2-vs-Stage4 |
5.671400E-01 |
| Stage3-vs-Stage4 |
3.943600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.420800E-04 |
| Normal-vs-AfricanAmerican |
2.178800E-01 |
| Normal-vs-Asian |
1.176440E-02 |
| Caucasian-vs-AfricanAmerican |
2.780600E-01 |
| Caucasian-vs-Asian |
8.317800E-01 |
| AfricanAmerican-vs-Asian |
4.035600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.23409999999813E-05 |
| Normal-vs-Female |
9.150200E-04 |
| Male-vs-Female |
1.308400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.498800E-03 |
| Normal-vs-Age(41-60Yrs) |
2.969100E-04 |
| Normal-vs-Age(61-80Yrs) |
5.439200E-04 |
| Normal-vs-Age(81-100Yrs) |
5.900300E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.568200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.052000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.156200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.758200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.639250E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.998000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.827200E-01 |
| Classical-VS-Follicular |
2.262400E-03 |
| Classical-VS-Other |
2.901800E-01 |
| Classical-VS-Normal |
5.342000E-03 |
| Tall-VS-Follicular |
4.020200E-01 |
| Tall-VS-Other |
6.011600E-01 |
| Tall-VS-Normal |
7.884900E-03 |
| Follicular-VS-Other |
9.755400E-01 |
| Follicular-VS-Normal |
2.18559999999313E-05 |
| Other-VS-Normal |
5.288200E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.65200000000243E-05 |
| Normal-vs-N1 |
5.803600E-03 |
| N0-vs-N1 |
6.839800E-01 |
|
|
